Reply to: "Evaluating the role of transient elastography post chronic hepatitis C treatment to predict hepatocellular carcinoma"

J Hepatol. 2020 Nov;73(5):1289-1290. doi: 10.1016/j.jhep.2020.07.031. Epub 2020 Aug 24.
No abstract available

Keywords: Hepatitis C; Hepatocellular carcinoma; Liver cirrhosis; Non-invasive liver fibrosis markers; Sustained virological response; cACLD.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • Carcinoma, Hepatocellular* / drug therapy
  • Elasticity Imaging Techniques*
  • Hepatitis C, Chronic* / complications
  • Hepatitis C, Chronic* / drug therapy
  • Humans
  • Liver
  • Liver Cirrhosis / diagnosis
  • Liver Cirrhosis / drug therapy
  • Liver Cirrhosis / etiology
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / etiology

Substances

  • Antiviral Agents